Triptolide induces apoptosis and synergizes with cisplatin in cisplatin-resistant HNE1/DDP nasopharyngeal cancer cells

Folia Biologica (Czech Republic)

Volumn 61, Issue 5, 2015, Pages 195-202

  Wang, X ^a   Zhang, J J ^a   Sun, Y M ^a   Zhang, J ^a   Wang, L R ^b   Li, J C ^a   Liu, H ^a  

^a BENGBU MEDICAL COLLEGE   (China)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CASPASE 9; CISPLATIN; GLUTATHIONE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MCL 1; REACTIVE OXYGEN METABOLITE; TRIPTOLIDE; ANTINEOPLASTIC AGENT; DITERPENE; EPOXIDE; PHENANTHRENE DERIVATIVE; TUMOR MARKER;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL SWELLING; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; LOW DRUG DOSE; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; NASOPHARYNX CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING; DRUG EFFECTS; DRUG POTENTIATION; DRUG RESISTANCE; METABOLISM; NASOPHARYNGEAL NEOPLASMS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DITERPENES; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; EPOXY COMPOUNDS; FLOW CYTOMETRY; HUMANS; NASOPHARYNGEAL NEOPLASMS; PHENANTHRENES;

EID: 84951788381     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Alsaied, O. A., Sangwan, V., Banerjee, S., Krosch, T. C., Chugh, R., Saluja, A., Vickers, S. M., Jensen, E. H. (2014) Sorafenib and triptolide as combination therapy for hepatocellular carcinoma. Surgery 156, 270-279.
2. Bao, L. L., Hazari, S., Mehra, S., M., Kaushal, D., Moroz, K., Dash, S. (2012) Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. Am. J. Pathol. 180, 2491-2503.
3. Bonora, M., Pinton, P. (2014). The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death. Front. Oncol. 4, 302.
4. Chen, F., Liu, Y., Wang, S., Guo, X., Shi, P., Wang, W., Xu, B. (2013) Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1α and Nrf2. Pharmacogenomics 14, 1305-1317.
5. Deeb, D., Gao, X., Jiang, H., Janic, B., Arbab, A. S., Rojanasakul, Y., Dulchavsky, S. A, Gautam, S. C. (2010) Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism. Biochem. Pharmacol. 79, 350-360.
6. Feng, X., Zhang, Q., Xia, S., Zhang, Y., Deng, X., Su. W., Huang, J. (2014) MTA1 overexpression induces cisplatin resistance in nasopharyngeal carcinoma by promoting cancer stem cells properties. Mol. Cells 37, 699-704.
7. Ho, J. N., Byun, S.S., Lee, S., Oh, J. J., Hong, S. K., Lee, S. E., Yeon, J. S. (2015) Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells. J. Urol. 193, 1016-1022.
8. Indran, I. R., Tufo, G., Pervaiz, S., Brenner, C. (2011) Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim. Biophys. Acta 1807, 735-745.
9. Li, C., Chu, C.-Y., Huang L.-H., Wang, M. H., Sheu, L. F., Yeh, J. I., Hsu, H. Y. (2012) Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo. Cancer Lett. 319, 203-213.
10. Li, X. J. Y., Jiang, Z. Z., Zhang, L. Y. (2014) Triptolide: Progress on research in pharmacodynamics and toxicology. J. Ethnopharmacol. 155, 67-79.
11. Liu, Q. Y. (2011) Triptolide and its expanding multiple pharmacological functions. Int. Immunopharmacol. 11, 377-383.
12. Marquitz, A. R., Raab-Traub, N. (2012) The role of miRNAs and EBV BARTs in NPC. Semin. Cancer Biol. 22, 166-172.
13. Pan, Y., Zhang, Q., Atsaves, V., Yang, H., Claret, F. X. (2013) Suppression of Jab1/CSN5 induces radio-and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways. Oncogene 32, 2756-2766.
14. Penney, R. B., Roy, D. (2013) Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer. Biochim. Biophys. Acta 1836, 60-79.
15. Rasola, A., Bernardi, P. (2014). The mitochondrial permeability transition pore and its adaptive responses in tumor cells. Cell Calcium 56, 437-445.
16. Sosa, V., Moline, T., Somoza, R., Paciucci, R., Kondoh, H., Leonart, M. E. (2013) Oxidative stress and cancer: an overview. Ageing Res. Rev. 12, 76-90.
17. Su, W. P., Hsu, S. H., Wu, C. K., Chang, S. B., Lin, Y. J., Yang, W. B., Hung, J. J., Chiu, W. T., Tzeng, S. F., Tseng, Y. L., Chang, J. Y., Su, W. C., Liaw, H. (2014) Chronic treatment with cisplatin induces replication-dependent sister chromatid recombination to confer cisplatin-resistant phenotype in nasopharyngeal carcinoma. Oncotarget 5, 6323-6237.
18. Sun, X. J., Zhang, P., Li, H. H., Jiang, Z. W., Jiang, C. C., Liu, H. (2014) Cisplatin combined with metformin inhibits migration and invasion of human nasopharyngeal carcinoma cells by regulating E-cadherin and MMP-9. Asian Pac. J. Cancer Prev. 15, 4019-4023.
19. Tan, B. J., Chiu, G. N. (2013) Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis. Int. J. Oncol. 42, 1605-4612.
20. Widlansky, M. E., Wang, J. L., Shenouda, S. M., Hagen, T. M., Smith, A. R., Kizhakekuttu, T. J., Kluge, M. A., Weihrauch, D., Gutterman, D. D., Vita, J. A. (2010) Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes. Transl. Res. 156, 15-25.
21. Ye, C. S., Zhou, D. N., Yang, Q. Q., Deng, Y. (2014). Silencing SATB1 influences cell invasion, migration, proliferation, and drug resistance in nasopharyngeal carcinoma. Int. J. Clin. Exp. Pathol. 7, 914-922.
22. Zhong, Y. Y., Chen, H. P., Tan, B. Z., Yu, H. H., Huang, X. S. (2013) Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species/nuclear factor-κB pathway in SKOV3 platinum-resistant human ovarian cancer cells. Oncol. Lett. 6, 1084-1092.
23. Zhou, Y. F., Sridhar, R., Shan, L., Sha, W., Gu, X., Sukumar, S. (2011) Loperamide, an FDA-approved antidiarrhea drug, effectively reverses the resistance of multidrug resistant MCF-7/MDR1 human breast cancer cells to doxorubicin-induced cytotoxicity. Cancer Invest. 30, 119-125.
24. Zhu, W., Li, J., Wu, S., Li, S., Le, L., Su, X., Qiu, P., Hu, H., Yan, G. (2012) Triptolide cooperates with cisplatin to induce apoptosis in gemcitabine-resistant pancreatic cancer. Pancreas 41, 1029-1038.